CLINICAL AND NEUROIMAGING FEATURES OF DIABETIC STRIATOPATHY: A 5-YEAR RETROSPECTIVE STUDY AT UNIVERSITY MEDICAL CENTER HO CHI MINH CITY, VIETNAM

Ngọc Tài Trần, Thị Minh Nguyệt Võ , Thái Thùy Ngân Nguyễn, Văn Tân Nguyễn

Main Article Content

Abstract

Background: Diabetic striatopathy (DS) is characterized by choreiform/ballistic movements and typical neuroimaging lesions in patients with diabetes mellitus. This is rare disease, so there have been no studies with a large enough sample size to analyze the clinical and neuroimaging features. Objective: To describe the clinical manifestations and neuroimaging features in the patients with diabetic striatopathy. Methods: This is a retrospective descriptive study of a total of 36 diabetic patients with clinical chorea/ballism and basal ganglia hyperintensity on brain MRI/CT with T1W sequence. Data were retrospectively collected from electronic medical records over 5 years (2018-2023) at the University Medical Center Ho Chi Minh City, Vietnam. Results: A total of 36 patients were included, with a mean age of 75,1 ± 11,6 years. The majority were elderly women, accounting for 83,3%. All patients had type 2 diabetes mellitus in which 16,67% were newly diagnosed. The average blood glucose concentration at the onset of movement disorders was 12,36 ± 7,57 mmol/L and HbA1c level was 11,25 ± 3,19%. Positive blood ketone was observed in 33,3% of cases. Brain MRI was performed in 32 patients, head CT was in 7, and 3 patients received both brain MRI and head CT. The characteristic findings of hyperintensity on T1W MRI and/or increased density on CT simultaneously in the globus pallidus and putamen were most common (53.1%). Clinically, two predominant movement disorders observed were chorea (72,2%) and ballism (27,78%). Hemichorea was the most common pattern (80,56%), followed by generalized chorea (19,44%) with facial involvement noted in 30,56% of cases. All patients have glycemia controlled. The most frequently prescribed antipsychotic was risperidone (66,67%), followed by haloperidol (33,33%) with a mean daily dosage of 3,139 ± 1,722 mg. 56.7% of the patients improved partially and 30% improved completely with choreiform symptoms. The average time to clinical improvement was 6,18 ± 7,1 days. Conclusion: Our study showed that clinical and neuroimaging features were typical in patients with diabetic striatopathy. Most choreiform symptoms improved partialy or completely after the treatment.

Article Details

References

1. Abbassi O, Kako AA, Mebrouk Y. Bilateral Chorea-Ballism Associated With Non-ketotic Hyperglycemia: A Case Report. Cureus. 2024;16(6).
2. Arecco A, Ottaviani S, Boschetti M, Renzetti P, Marinelli L. Diabetic striatopathy: an updated overview of current knowledge and future perspectives. Journal of Endocrinological Investigation. 2024;47(1):1-15.
3. Bedwell SF. Some observations on hemiballismus. Neurology. 1960;10(6):619-.
4. Chua C-B, Sun C-K, Hsu C-W, Tai Y-C, Liang C-Y, Tsai I-T. “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes. Scientific reports. 2020;10(1):1594.
5. Morgan HD, ur Rehman A, Morrison AE, Harieaswar S, Jackson S, Kong M-F. Diabetic striatopathy: a rare complication of hyperglycaemia. British Journal of Diabetes. 2025.
6. Ottaviani S, Arecco A, Boschetti M, Ottaviani E, Renzetti P, Marinelli L. Prevalence of diabetic striatopathy and predictive role of glycated hemoglobin level. Neurological Sciences. 2022;43(10):6059-65.
7. Ryan C, Ahlskog JE, Savica R. Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center. Parkinsonism & related disorders. 2018;48:97-100.
8. Walker RH. Differential diagnosis of chorea. Current neurology and neuroscience reports. 2011;11(4):385-95.